Literature DB >> 19923578

Inflammatory bowel disease.

Clara Abraham1, Judy H Cho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19923578      PMCID： PMC3491806          DOI： 10.1056/NEJMra0804647

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  108 in total

1.  Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis.

Authors:  Seth Rakoff-Nahoum; Justin Paglino; Fatima Eslami-Varzaneh; Stephen Edberg; Ruslan Medzhitov
Journal:  Cell       Date:  2004-07-23       Impact factor: 41.582

2.  CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.

Authors:  Jan Hendrik Niess; Stephan Brand; Xiubin Gu; Limor Landsman; Steffen Jung; Beth A McCormick; Jatin M Vyas; Marianne Boes; Hidde L Ploegh; James G Fox; Dan R Littman; Hans-Christian Reinecker
Journal:  Science       Date:  2005-01-14       Impact factor: 47.728

3.  Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity.

Authors:  Lesley E Smythies; Marty Sellers; Ronald H Clements; Meg Mosteller-Barnum; Gang Meng; William H Benjamin; Jan M Orenstein; Phillip D Smith
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

4.  Anti-interleukin-12 antibody for active Crohn's disease.

Authors:  Peter J Mannon; Ivan J Fuss; Lloyd Mayer; Charles O Elson; William J Sandborn; Daniel Present; Ben Dolin; Nancy Goodman; Catherine Groden; Ronald L Hornung; Martha Quezado; Zhiqiong Yang; Markus F Neurath; Jochen Salfeld; Geertruida M Veldman; Ullrich Schwertschlag; Warren Strober
Journal:  N Engl J Med       Date:  2004-11-11       Impact factor: 91.245

5.  Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis.

Authors:  Michael Economou; Thomas A Trikalinos; Konstantinos T Loizou; Epameinondas V Tsianos; John P A Ioannidis
Journal:  Am J Gastroenterol       Date:  2004-12       Impact factor: 10.864

6.  Retinoic acid imprints gut-homing specificity on T cells.

Authors:  Makoto Iwata; Asami Hirakiyama; Yuko Eshima; Hiroyuki Kagechika; Chieko Kato; Si-Young Song
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

7.  CD4+CD25bright T cells in human intestinal lamina propria as regulatory cells.

Authors:  Shin Makita; Takanori Kanai; Shigeru Oshima; Koji Uraushihara; Teruji Totsuka; Taisuke Sawada; Tetsuya Nakamura; Kazutaka Koganei; Tsuneo Fukushima; Mamoru Watanabe
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

8.  Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease.

Authors:  Timothy S Olson; Giorgos Bamias; Makoto Naganuma; Jesús Rivera-Nieves; Tracy L Burcin; William Ross; Margaret A Morris; Theresa T Pizarro; Peter B Ernst; Fabio Cominelli; Klaus Ley
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

9.  Human neonatal Fc receptor mediates transport of IgG into luminal secretions for delivery of antigens to mucosal dendritic cells.

Authors:  Masaru Yoshida; Steven M Claypool; Jessica S Wagner; Emiko Mizoguchi; Atsushi Mizoguchi; Derry C Roopenian; Wayne I Lencer; Richard S Blumberg
Journal:  Immunity       Date:  2004-06       Impact factor: 31.745

10.  Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy.

Authors:  Mohamed Elfatih H Bashir; Steve Louie; Hai Ning Shi; Cathryn Nagler-Anderson
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422
View more
  992 in total

1.  Styrene maleic acid encapsulated raloxifene micelles for management of inflammatory bowel disease.

Authors:  Khaled Greish; Safa Taha; Anfal Jasim; Sara Abd Elghany; Ameera Sultan; Ali AlKhateeb; Manal Othman; Fang Jun; Sebastien Taurin; Moiz Bakhiet
Journal:  Clin Transl Med       Date:  2017-08-03

2.  Adenosine A2A receptor contributes to the anti-inflammatory effect of the fixed herbal combination STW 5 (Iberogast®) in rat small intestinal preparations.

Authors:  Sebastian Michael; Heba Abdel-Aziz; Dieter Weiser; Christa E Müller; Olaf Kelber; Karen Nieber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-12-10       Impact factor: 3.000

3.  Association of TNFSF15 polymorphism with irritable bowel syndrome.

Authors:  Marco Zucchelli; Michael Camilleri; Anna Nixon Andreasson; Francesca Bresso; Aldona Dlugosz; Jonas Halfvarson; Leif Törkvist; Peter T Schmidt; Pontus Karling; Bodil Ohlsson; Richard H Duerr; Magnus Simren; Greger Lindberg; Lars Agreus; Paula Carlson; Alan R Zinsmeister; Mauro D'Amato
Journal:  Gut       Date:  2011-06-02       Impact factor: 23.059

Review 4.  MMX® Mesalazine: a review of its use in the management of mild to moderate ulcerative colitis.

Authors:  Lily P H Yang; Paul L McCormack
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

5.  Pivotal role of NOD2 in inflammatory processes affecting atherosclerosis and periodontal bone loss.

Authors:  Huaiping Yuan; Sami Zelkha; Sami Zelka; Marina Burkatovskaya; Rohit Gupte; Susan E Leeman; Salomon Amar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-09       Impact factor: 11.205

6.  Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome.

Authors:  Marjorie De la Fuente; Luigi Franchi; Daniela Araya; David Díaz-Jiménez; Mauricio Olivares; Manuel Álvarez-Lobos; Douglas Golenbock; María-Julieta González; Francisco López-Kostner; Rodrigo Quera; Gabriel Núñez; Roberto Vidal; Marcela A Hermoso
Journal:  Int J Med Microbiol       Date:  2014-02-06       Impact factor: 3.473

Review 7.  Ulcerative Colitis: Update on Medical Management.

Authors:  Heba N Iskandar; Tanvi Dhere; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2015-11

Review 8.  Genetically engineered mouse models for studying inflammatory bowel disease.

Authors:  Atsushi Mizoguchi; Takahito Takeuchi; Hidetomo Himuro; Toshiyuki Okada; Emiko Mizoguchi
Journal:  J Pathol       Date:  2015-11-14       Impact factor: 7.996

9.  JAK2 Disease-Risk Variants Are Gain of Function and JAK Signaling Threshold Determines Innate Receptor-Induced Proinflammatory Cytokine Secretion in Macrophages.

Authors:  Matija Hedl; Deborah D Proctor; Clara Abraham
Journal:  J Immunol       Date:  2016-09-23       Impact factor: 5.422

Review 10.  Regulation of intestinal microbiota by the NLR protein family.

Authors:  Amlan Biswas; Koichi S Kobayashi
Journal:  Int Immunol       Date:  2013-01-15       Impact factor: 4.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.